Heinrich Terahertz podcast: St Petersburg University physicist talks about how basic science paved the way for nuclear medicine
Vladimir Zherebchevskii, Head of the Laboratory of Nuclear Processes, Associate Professor at St Petersburg University, was the guest of the fourth series of the popular science podcast "Heinrich Terahertz". He talked about how nuclear technologies treat cancer patients, what theranostics is and how dangerous it is to use nuclear technologies in medicine.
The use of nuclear technology in medicine is not only one of the most innovative, but also one of the most controversial methods in medicine. Although this technology was discovered more than a hundred years ago, it only officially became a branch of medicine in the 1970s.
Vladimir Zherebchevskii talked about how the initial basic research led to major breakthroughs in the field. Vladimir Zherebchevskii also explained what theranostics is — a method that combines therapy and diagnostics. According to him, theranostics is a promising field that may soon determine the future of nuclear medicine. The scientist also said that people should not believe in myths and be afraid of nuclear technologies in medicine. These technologies are tested by basic science and do not contain anything dangerous for humans.
"There are systems of accounting and control of doses, and there are very strict rules. In our country, they are among the strictest in the world. They are so strict that they are even hindering the development of nuclear medicine. So, there is definitely nothing to be afraid of, and the benefits are obviously much greater. Dear listeners, it is necessary to use different sources, not to believe in myths and legends. You should create your own view of the world, even in the field of nuclear physics," said Vladimir Zherebchevskii.
The team of scientists led by Vladimir Zherebchevskii is investigating radionuclides that hold promise for the diagnosis and treatment of oncological diseases. The scientists are carrying out nuclear reactions using a specially designed target device to produce radionuclides for further use in the diagnosis and treatment of cancer.